ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. Post author:admERY Post published:June 17, 2012 Post category:Newsroom You Might Also Like ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2019 November 7, 2019 ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017 March 12, 2018 ERYTECH to Present at Morgan Stanley Global Healthcare Conference September 12, 2017
ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2019 November 7, 2019
